Suchergebnisse - Markus Cornberg

Treffer weiter einschränken
  1. 1
    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity von Markus Cornberg

    Veröffentlicht 2006
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability

    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability von Markus Cornberg, Frank Tacke, Tom H. Karlsen

    Veröffentlicht 2018
    Volltext Volltext
    Editorial
    Zu den Favoriten
    Gespeichert in:
  3. 3
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients von Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Veröffentlicht 2021
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Natural killer cells act as rheostats modulating antiviral T cells

    Natural killer cells act as rheostats modulating antiviral T cells von Stephen N. Waggoner, Markus Cornberg, Liisa K. Selin, Raymond M. Welsh

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference

    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference von Markus Cornberg, Anna Suk‐Fong Lok, Norah A. Terrault, Fabien Zoulim

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C von Julia Hengst, Christine S. Falk, Verena Schlaphoff, Katja Deterding, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis

    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis von Tammo Lambert Tergast, Markus Kimmann, H. Laser, Svetlana Gerbel, Michael P. Manns, Markus Cornberg, Benjamin Maasoumy

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper von Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Matičič, Elisa Cordero, Markus Cornberg, Thomas Berg

    Veröffentlicht 2020
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Private specificities of CD8 T cell responses control patterns of heterologous immunity

    Private specificities of CD8 T cell responses control patterns of heterologous immunity von Sung-Kwon Kim, Markus Cornberg, Xiaoting Z. Wang, Hong D. Chen, Liisa K. Selin, Raymond M. Welsh

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp>

    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp> von Katja Deterding, Cheng‐Jian Xu, Kerstin Port, Christopher Dietz‐Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection von A. Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa‐Breier, J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss von Christine L. Zimmer, Franziska Rinker, Christoph Höner zu Siederdissen, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Niklas K. Björkström

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity von Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    EASL Clinical Practice Guidelines on haemochromatosis

    EASL Clinical Practice Guidelines on haemochromatosis von Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, Bill Griffiths, Edouard Bardou–Jacquet, Elena Corradini, Graça Porto, John Ryan, Markus Cornberg

    Veröffentlicht 2022
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection von Lisa Sandmann, Valerie Ohlendorf, Alena Friederike Ehrenbauer, Birgit Bremer, Anke Kraft, Markus Cornberg, Katja Deterding, Heiner Wedemeyer, Benjamin Maasoumy

    Veröffentlicht 2025
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity

    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity von Liisa K. Selin, Michael A. Brehm, Yuri N. Naumov, Markus Cornberg, Sung‐Kwon Kim, Shalyn C. Clute, Raymond M. Welsh

    Veröffentlicht 2006
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Treatment of Acute Hepatitis C with Interferon Alfa-2b

    Treatment of Acute Hepatitis C with Interferon Alfa-2b von Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer, Teresa Santantonio, Julika Mayer, M Zankel, Giuseppe Pastore, Manfred Dietrich, Christian Trautwein, Michael P. Manns

    Veröffentlicht 2001
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study

    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study von Markus Cornberg, Johannes Hadem, Eva Herrmann, Frank Schuppert, Hartmut Schmidt, Markus Reiser, Oliver Marschal, Martín Steffen, Michael P. Manns, Heiner Wedemeyer

    Veröffentlicht 2005
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort von Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg, David Back, Heiner Wedemeyer

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhos... von F Mettke, Bernhard Schlevogt, Katja Deterding, A. Wranke, Andrea Smith, Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: